α-Methyltryptamine is a psychedelic drug that has schedule I status in the United States. It potently stimulates the release of monoamines from synaptosomes and inhibits their re-uptake (IC50s = 0.73, 0.38, and 0.4 μM for dopamine, serotonin, and norepinephrine, respectively). This product is intended for forensic use.
